133 related articles for article (PubMed ID: 9834823)
41. A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer.
Basaran M; Bavbek SE; Güllü I; Demirelli F; Sakar B; Tenekeci N; Altun M; Yalçin S; Onat H
J Chemother; 2002 Apr; 14(2):207-13. PubMed ID: 12017379
[TBL] [Abstract][Full Text] [Related]
42. Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck.
Vermorken JB; Licitra L; Stöhlmacher-Williams J; Dietz A; Lopez-Picazo JM; Hamid O; Hossain AM; Chang SC; Gauler TC
Eur J Cancer; 2013 Sep; 49(13):2877-83. PubMed ID: 23726971
[TBL] [Abstract][Full Text] [Related]
43. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
[TBL] [Abstract][Full Text] [Related]
44. Weekly schedule of vinorelbine in pretreated breast cancer patients.
Nisticò C; Garufi C; Milella M; Vaccaro A; D'Ottavio AM; Fabi A; Pace A; Bove L; Tropea F; Marsella A; Izzo F; D'Attino RM; Ferraresi V; De Marco S; Terzoli E
Breast Cancer Res Treat; 2000 Feb; 59(3):223-9. PubMed ID: 10832592
[TBL] [Abstract][Full Text] [Related]
45. Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer.
Burger RA; DiSaia PJ; Roberts JA; O'rourke M; Gershenson DM; Homesley HD; Lichtman SM; Barnes W; Moore DH; Monk BJ
Gynecol Oncol; 1999 Feb; 72(2):148-53. PubMed ID: 10021293
[TBL] [Abstract][Full Text] [Related]
46. Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma.
Lacava JA; Leone BA; Machiavelli M; Romero AO; Perez JE; Elem YL; Ferreyra R; Focaccia G; Suttora G; Salvadori MA; Cuevas MA; Acuña LR; Acuña JR; Langhi M; Amato S; Castaldi J; Arroyo A; Vallejo CT
J Clin Oncol; 1997 Feb; 15(2):604-9. PubMed ID: 9053483
[TBL] [Abstract][Full Text] [Related]
47. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
[TBL] [Abstract][Full Text] [Related]
48. Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study.
Gridelli C; Guida C; Barletta E; Gatani T; Fiore F; Barzelloni ML; Rossi A; de Bellis M; D'Aniello R; Scognamiglio F
Lung Cancer; 2000 Aug; 29(2):131-7. PubMed ID: 10963843
[TBL] [Abstract][Full Text] [Related]
49. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
Hussain M; Salwen W; Kucuk O; Ensley J
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-43-S19-45. PubMed ID: 9427265
[TBL] [Abstract][Full Text] [Related]
50. Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study.
Terenziani M; Demicheli R; Brambilla C; Ferrari L; Moliterni A; Zambetti M; Caraceni A; Martini C; Bonadonna G
Breast Cancer Res Treat; 1996; 39(3):285-91. PubMed ID: 8877008
[TBL] [Abstract][Full Text] [Related]
51. A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck.
Couteau C; Chouaki N; Leyvraz S; Oulid-Aissa D; Lebecq A; Domenge C; Groult V; Bordessoule S; Janot F; De Forni M; Armand JP
Br J Cancer; 1999 Oct; 81(3):457-62. PubMed ID: 10507770
[TBL] [Abstract][Full Text] [Related]
52. Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience.
Bruno S; Puerto VL; Mickiewicz E; Hegg R; Texeira LC; Gaitan L; Martinez L; Fernandez O; Otero J; Kesselring G
Am J Clin Oncol; 1995 Oct; 18(5):392-6. PubMed ID: 7572754
[TBL] [Abstract][Full Text] [Related]
53. Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus.
Bidoli P; Stani SC; De Candis D; Cortinovis D; Parra HS; Bajetta E
Tumori; 2001; 87(5):299-302. PubMed ID: 11765177
[TBL] [Abstract][Full Text] [Related]
54. Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study.
Genet D; Cupissol D; Calais G; Bontemps P; Bourgeois H; Dutin JP; Philippi MH; Bendahmane B; Mallard-Carre M; Tubiana-Mathieu N
Am J Clin Oncol; 2004 Oct; 27(5):472-6. PubMed ID: 15596913
[TBL] [Abstract][Full Text] [Related]
55. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
56. A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.
Argiris A; Cohen E; Karrison T; Esparaz B; Mauer A; Ansari R; Wong S; Lu Y; Pins M; Dancey J; Vokes E
Cancer Biol Ther; 2006 Jul; 5(7):766-70. PubMed ID: 16760642
[TBL] [Abstract][Full Text] [Related]
57. Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer.
Tahara M; Minami H; Hasegawa Y; Tomita K; Watanabe A; Nibu K; Fujii M; Onozawa Y; Kurono Y; Sagae D; Seriu T; Tsukuda M
Cancer Chemother Pharmacol; 2011 Sep; 68(3):769-76. PubMed ID: 21181475
[TBL] [Abstract][Full Text] [Related]
58. A phase I study of a fixed dose of cisplatin with increasing doses of raltitrexed (Tomudex) in the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck.
ten Bokkel Huinink D; Tesselaar ME; Baatenburg de Jong RJ; Verschuur HP; Keizer HJ
Ann Oncol; 2001 Mar; 12(3):357-63. PubMed ID: 11332149
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study.
Muggia FM; Blessing JA; Waggoner S; Berek JS; Monk BJ; Sorosky J; Pearl ML
Gynecol Oncol; 2005 Jan; 96(1):108-11. PubMed ID: 15589588
[TBL] [Abstract][Full Text] [Related]
60. Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.
Nolè F; de Braud F; Aapro M; Minchella I; De Pas TM; Zampino MG; Monti S; Andreoni G; Goldhirsch A
Ann Oncol; 1997 Sep; 8(9):865-70. PubMed ID: 9358936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
